Vogt-Koyanagi-Harada disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3437H20.8H30.8
Who is this for?
Show terms as
1Active trials5Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Vogt-Koyanagi-Harada disease (often called VKH disease) is a rare condition in which the body's immune system mistakenly attacks cells that contain melanin, a pigment found in the eyes, skin, inner ear, and the membranes surrounding the brain. It is not inherited in a simple genetic pattern but is considered an autoimmune disorder that occurs in people with certain genetic predispositions, particularly specific HLA (human leukocyte antigen) types. The disease typically progresses through several stages. It often begins with headaches, neck stiffness, fever, and flu-like symptoms. Within days, patients develop serious eye inflammation, including blurred vision, eye pain, sensitivity to light, and sometimes detachment of the retina. If untreated, VKH can lead to permanent vision loss. Later stages may involve whitening of the hair (poliosis), loss of skin color in patches (vitiligo), and hearing problems such as ringing in the ears or hearing loss. Treatment focuses on suppressing the immune system to control inflammation. High-dose corticosteroids are the first-line therapy, often followed by steroid-sparing immunosuppressive medications for long-term management. Early and aggressive treatment is critical to preserving vision and preventing recurrences. With proper treatment, many patients can maintain useful vision, though chronic or recurrent inflammation may lead to complications like glaucoma, cataracts, or ongoing vision problems.

Also known as:

Key symptoms:

Blurred or decreased visionEye pain and rednessSensitivity to lightFloaters in visionHeadachesNeck stiffnessRinging in the ears (tinnitus)Hearing lossWhitening or graying of hair and eyelashesPatches of skin losing color (vitiligo)Fever and flu-like symptoms early onNauseaPain with eye movementSwelling of the optic discHair loss (alopecia)

Clinical phenotype terms (37)— hover any for plain English
VitiligoHP:0001045PoliosisHP:0002290CSF pleocytosisHP:0012229IridocyclitisHP:0001094Posterior subcapsular cataractHP:0007787
Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jun 2021A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

Tianjin Medical University

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Vogt-Koyanagi-Harada disease.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
Actively Recruiting
· Sites: Tianjin, Tianjin Municipality · Age: 1870 yrs

Specialists

5 foundView all specialists →
JM
Joyce H Yamamoto, MD
Specialist
PI on 2 active trials
VM
Viviane M Sakata, MD
Specialist
PI on 1 active trial
MM
Marwa Abdelshafy, MD
Specialist
PI on 1 active trial
AM
Ahmed Abdelshafy, MD
CHENEY, WA
Specialist
PI on 1 active trial1 Vogt-Koyanagi-Harada disease publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Vogt-Koyanagi-Harada disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Vogt-Koyanagi-Harada diseaseForum →

No community posts yet. Be the first to share your experience with Vogt-Koyanagi-Harada disease.

Start the conversation →

Latest news about Vogt-Koyanagi-Harada disease

No recent news articles for Vogt-Koyanagi-Harada disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my VKH disease, and how much damage has already occurred in my eyes?,How long will I need to take immunosuppressive medications, and what are the risks?,What signs should I watch for that would indicate a disease flare?,Are there newer or biologic treatments that might be appropriate for me?,How often will I need eye exams and blood tests to monitor my condition?,What is my long-term outlook for preserving my vision?,Should I see other specialists such as a dermatologist or audiologist for my other symptoms?

Common questions about Vogt-Koyanagi-Harada disease

What is Vogt-Koyanagi-Harada disease?

Vogt-Koyanagi-Harada disease (often called VKH disease) is a rare condition in which the body's immune system mistakenly attacks cells that contain melanin, a pigment found in the eyes, skin, inner ear, and the membranes surrounding the brain. It is not inherited in a simple genetic pattern but is considered an autoimmune disorder that occurs in people with certain genetic predispositions, particularly specific HLA (human leukocyte antigen) types. The disease typically progresses through several stages. It often begins with headaches, neck stiffness, fever, and flu-like symptoms. Within days,

How is Vogt-Koyanagi-Harada disease inherited?

Vogt-Koyanagi-Harada disease follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Vogt-Koyanagi-Harada disease typically begin?

Typical onset of Vogt-Koyanagi-Harada disease is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Vogt-Koyanagi-Harada disease?

Yes — 1 recruiting clinical trial is currently listed for Vogt-Koyanagi-Harada disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Vogt-Koyanagi-Harada disease?

5 specialists and care centers treating Vogt-Koyanagi-Harada disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.